Purpose of the company: Research, development (including development for third parties), and sale of substances, products, and active ingredients for use in medical diagnostics and therapy.
Share capital: 42.517 EUR
Adress: Magnusstr. 11 12489 Berlin Deutschland
Local court: 14057 Berlin (Charlottenburg)
Register number: HRB118255B
The average total assets of company 3B Pharmaceuticals GmbH over the last 12 years is 11.234.595,25 âŹ.
The company 3B Pharmaceuticals GmbH as of the reporting date 2023 a bank balance of approx. 29.814.100,29 âŹ. That is 127,51 % more than the average bank balance in the industry of companies with this total assets.
The equity ratio of 3B Pharmaceuticals GmbH is 52,75 % in the year 2023. In total, that ist 23.454.593,79 âŹ.
The average number of employees of the company 3B Pharmaceuticals GmbH for the years 2016 - 2023 is 33.
The average absolute change in liquidity of the company 3B Pharmaceuticals GmbH compared to the previous year amounts to 1.835.948,87 âŹ. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company 3B Pharmaceuticals GmbH amounts to 20.195.437,57 ⏠in the year 2023.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.